Item 1. | Security And Issuer. |
This Amendment No. 9 (this "Amendment No. 9") to the Statement of Beneficial Ownership on Schedule 13D filed on June 2, 2016 (the "Statement"), as amended by Amendment No. 1 thereto filed on August 29, 2016 ("Amendment No. 1"), Amendment No. 2 thereto filed on November 23, 2016 ("Amendment No. 2"), Amendment No. 3 thereto filed on January 25, 2017 ("Amendment No. 3"), Amendment No. 4 thereto filed on February 6, 2017 ("Amendment No. 4"), Amendment No. 5 thereto filed on February 27, 2017 ("Amendment No. 5"), Amendment No. 6 thereto filed on August 18, 2017 ("Amendment No. 6"), Amendment No. 7 thereto filed on September 6, 2017 ("Amendment No. 7") and Amendment No. 8 thereto filed on September 28, 2017 ("Amendment No. 8"), relates to the Ordinary Shares, NIS 0.03 par value per share ("Ordinary Shares") of RADA Electronic Industries Ltd., an Israeli company (the "Issuer" or "RADA"). Capitalized terms used herein that are not otherwise defined shall have the respective meanings assigned thereto in the Statement and/or in Amendments No. 1, No. 2, No. 3, No. 4, No. 5, No. 6, No. 7 and No. 8.
This Amendment No. 9 is being filed by the Reporting Persons to report (i) the sale by DBSI (as defined in Item 2 below), in open market transactions entered into from October 10, 2017 through October 25, 2017, of an additional 1,022,037 Initial Shares, in the aggregate, that had been acquired by it at the Closing, and (ii) the exercise by DBSI, on October 24, 2017, of 1,363,636 Warrants to purchase 1,363,636 Second Warrant Shares at an exercise price of $0.55 per share for an aggregate exercise price of $750,000. The foregoing transactions have increased, in the aggregate, the number of Ordinary Shares actually held by DBSI relative to the number reported in Amendment No. 8 (while decreasing the number of, and the percentage (by greater than 1%) of the outstanding, Ordinary Shares beneficially owned by DBSI and the other Reporting Persons, due to the reduction in the remaining number of Warrants held by DBSI resulting from the above-described exercise of Warrants).
Except as modified by the information provided in this Item 1, the information set forth in Item 1 of the Statement, as supplemented by the information that appeared in Item 1 of Amendments No. 1, No. 2, No. 3, No. 4, No. 5, No. 6, No. 7 and No. 8, is incorporated by reference herein in response to the disclosure requirements of Item 1 of Schedule 13D.
Item 2. | Identity and Background |
This Amendment No. 9 is being filed by each of (1) DBSI Investments Ltd. ("DBSI" or the "Reporting Entity"), (2) Barak Dotan and (3) Yossi Ben Shalom.
Messrs. Dotan and Ben Shalom are together referred to sometimes hereafter as the “Reporting Individuals”, and, together with the Reporting Entity, the “Reporting Persons”.
The information set forth in the Statement in response to:
| · | paragraphs (b)-(c) and (f) of Item 2, concerning DBSI; |
| · | paragraphs (a), (b), (c) and (f) of Item 2, concerning DBSI’s executive officers and directors; |
| · | paragraphs (a), (b), (c) and (f) of Item 2, concerning DBSI’s controlling shareholders; |
| · | paragraphs (b)-(c) and (f) of Item 2, concerning Mr. Barak Dotan; and |
| · | paragraphs (b)-(c) and (f) of Item 2, concerning Mr. Yossi Ben Shalom |
is in each case incorporated by reference herein in response to the disclosures required by the corresponding paragraphs of this Amendment No. 9.
(d) Criminal Proceedings: The information set forth in the corresponding paragraph of the Statement (with respect to each of (i) DBSI, its executive officers and directors, and its controlling shareholders, (ii) Mr. Barak Dotan and (iii) Mr. Yossi Ben Shalom) is incorporated by reference herein.
(e) Civil Proceedings: The information set forth in the corresponding paragraph of the Statement (with respect to each of (i) DBSI, its executive officers and directors, and its controlling shareholders, (ii) Mr. Barak Dotan and (iii) Mr. Yossi Ben Shalom) is incorporated by reference herein.
Item 3. | Source and Amount of Funds or Other Consideration. |
The internal funds of DBSI served as the source of funds for the exercise by DBSI of Warrants to purchase 1,363,636 Second Warrant Shares at an exercise price of $0.55 per share for an aggregate exercise price of $750,000, as reported in this Amendment No. 9.
Item 4. | Purpose of Transaction. |
The information set forth in the corresponding paragraph of the Statement with respect to DBSI (and, indirectly, the Reporting Individuals) is incorporated by reference herein. In addition, the Reporting Persons note that DBSI may be required to dispose of up to 180,000 Ordinary Shares to Sphera Capital pursuant to exercise(s) by Sphera Capital of the Sphera Capital Option up until January 31, 2018.
DBSI reserves the right at any time to change its present intention with respect to any or all of the matters referred to in this Item 4, or to dispose of any or all of the securities of RADA purchased by it.
Except as set forth in this Item 4, DBSI has no current plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, although DBSI does not rule out the possibility of effecting or seeking to effect any such actions in the future.
Item 5. | Interest in Securities of the Issuer. |
All calculations of beneficial ownership percentage in this Amendment No. 9 are made on the basis of 31,345,763 Ordinary Shares outstanding as of October 24, 2017, which is based on information provided to DBSI by the Issuer upon DBSI's inquiry.
(a) DBSI is the beneficial owner of 10,781,634 Ordinary Shares of the Issuer, constituting 32.9% of the issued and outstanding Ordinary Shares of the Issuer. Such number of Ordinary Shares consists of the following:
(i) | 2,889,951 remaining Ordinary Shares from among the Initial Shares purchased by DBSI from the Issuer at the Closing; |
(ii) | 4,255,319 First Warrant Shares, in the aggregate, issued to DBSI upon exercise of Warrants on August 29, 2016, November 9, 2016, January 18, 2017 and August 17, 2017; |
(iii) | 2,181,818 Second Warrant Shares, in the aggregate, issued to DBSI upon exercise of Warrants on September 6, 2017, September 24, 2017 and October 24, 2017; and |
(iv) | 1,454,546 additional Second Warrant Shares issuable to DBSI upon exercise of outstanding Warrants held by it. |
(c) During the past 60 days, DBSI has effected the transactions with respect to Ordinary Shares described in paragraph (c) of Item 5 of each of Amendment No. 7 and Amendment No. 8, and, in addition, since the filing of Amendment No. 8, has effected the following additional transactions with respect to Ordinary Shares:
Type of Transaction and Date | | Quantity of Ordinary Shares Sold/Purchased | | | Price Per Share | | | Total ($) | |
Sales: | |
October 10, 2017 | | | (118,080 | )* | | $ | 3.54818 | | | $ | 418,969 | |
October 11, 2017 | | | (119,703 | )* | | $ | 3.559 | | | $ | 426,023 | |
October 12, 2017 | | | (245,309 | )* | | $ | 3.69694 | | | $ | 906,893 | |
October 13, 2017 | | | (122,584 | )* | | $ | 3.52846 | | | $ | 432,533 | |
October 16, 2017 | | | (101,422 | )* | | $ | 3.55278 | | | $ | 360,330 | |
October 17, 2017 | | | (128,400 | )* | | $ | 3.5394 | | | $ | 454,459 | |
October 18, 2017 | | | (10,395 | )* | | $ | 3.50409 | | | $ | 36,425 | |
October 19, 2017 | | | (48,294 | )* | | $ | 3.50823 | | | $ | 169,426 | |
October 20, 2017 | | | (64,201 | )* | | $ | 3.53689 | | | $ | 227,072 | |
October 23, 2017 | | | (49,554 | )* | | $ | 3.5305 | | | $ | 174,950 | |
October 24, 2017 | | | (10,123 | )* | | $ | 3.50447 | | | $ | 35,476 | |
October 25, 2017 | | | (3,972 | )* | | $ | 3.50 | | | $ | 13,902 | |
Purchase of Shares vis Exercise of Warrants: | |
October 24, 2017 | | | 1,363,636 | ** | | $ | 0.55 | | | $ | 750,000 | |
(*) This was a sale of Initial Shares purchased by DBSI from the Issuer at the Closing. (**) These are Second Warrant Shares issued upon exercise of Warrants issued to DBSI at the Closing. | |
Except as described in this Amendment No. 9, none of the Reporting Persons has effected any transactions in the Ordinary Shares (or other securities of RADA convertible into, or exercisable for, Ordinary Shares) in the past 60 days.
(d) Not applicable.
(e) Not applicable.
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. |
Registration Rights
The description in Item 6 of the Statement of the registration rights granted by the Issuer to DBSI under each of the Purchase Agreement and the Registration Rights Agreement is incorporated by reference in response to this Item 6. Pursuant to those registration rights, as described in Amendment No. 1, the Issuer filed a shelf registration statement on Form F-3 with the SEC on June 15, 2016, for the public resale by DBSI of up to 5,299,655 Initial Shares (which constituted 2,649,828 Ordinary Shares following the Reverse Share Split), which was declared effective by the SEC on June 22, 2016. Also pursuant to those registration rights, on March 27, 2017, the Issuer filed an additional shelf registration statement on Form F-3 with the SEC, for the public resale by DBSI of up to 4,351,568 Ordinary Shares, which was declared effective by the SEC on March 31, 2017. Furthermore, on September 1, 2017, the Issuer filed an additional shelf registration statement on Form F-3 with the SEC, for the public resale by DBSI of up to 3,549,071 additional Ordinary Shares, which was declared effective by the SEC on September 13, 2017.
Rights to Acquire Additional Shares
Warrants
The description in Item 6 of the Statement of the Warrants issued by the Issuer to DBSI at the Closing is incorporated by reference in response to this Item 6. In addition, as reported in Items 1 and 5(c) of Amendment No. 1, in Items 1 and 5(c) of Amendment No. 2, in Items 1 and 5(c) of Amendment No. 3, in Items 1 and 5(c) of Amendment No. 6, in Items 1 and 5(c) of Amendment No. 7, and in Items 1 and 5(c) of this Amendment No. 8 since the filing of the Statement— on August 29, 2016, November 9, 2016, January 18, 2017, August 17, 2017, September 6, 2017, September 24, 2017 and October 24, 2017— DBSI exercised Warrants to purchase 531,915, 2,127,660, 531,915 and 1,063,829 First Warrant Shares and 181,818, 636,364 and 1,363,636 Second Warrant Shares, respectively.
Sphera Capital Option
The description of the Sphera Capital Option set forth in Item 6 of Amendment No. 5 is incorporated by reference in response to this Item 6.
Other than as described above in this Item 6, to the best knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, put or calls, guarantors of profit, division of profit or loss or the giving or withholding of proxies.
Item 7. | Materials to be Filed as Exhibits. |
The following exhibits are filed herewith or incorporated by reference herein (as indicated below):
Exhibit No. | | Description |
| | |
1 | | Purchase Agreement, dated as of April 14, 2016, by and between the Issuer and DBSI (incorporated by reference to Exhibit 4.4 to the Issuer’s Annual Report on Form 20-F for the year ended December 31, 2015, filed with the SEC on May 16, 2016 (hereafter, the “Issuer’s 2015 Form 20-F”)) |
| | |
2 | | Registration Rights Agreement, dated as of April 14, 2016, by and between the Issuer and DBSI (incorporated by reference to Exhibit 4.5 to the Issuer’s 2015 Form 20-F) |
| | |
3 | | Warrant to Purchase Ordinary Shares of the Issuer, dated April 14, 2016, issued by the Issuer to DBSI (incorporated by reference to Exhibit 4.8 to the Issuer’s 2015 Form 20-F) |
| | |
4 | | English summary of Option to Purchase Ordinary Shares of the Issuer, granted by DBSI to Sphera Capital Ltd. on January 25, 2017 (incorporated by reference to Exhibit 6 to Amendment No. 5) |
| | |
5 | | Joint Filing Agreement pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended* |
_____________________
*Filed herewith.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: October 30, 2017
DBSI INVESTMENTS LTD. | |
/s/ Barak Dotan |
Barak Dotan |
Director |
/s/ Yossi Ben Shalom |
Yossi Ben Shalom |
Director |
/s/ Barak Dotan
BARAK DOTAN
/s/ Yossi Ben Shalom
YOSSI BEN SHALOM